Related Experiment Video
Updated: May 1, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Integrative clinical transcriptomics analyses for new therapeutic intervention strategies: a psoriasis case study
Xiaoyan A Qu1, Johannes M Freudenberg1, Philippe Sanseau2
1Computational Biology, Quantitative Sciences, GlaxoSmithKline R&D, RTP, NC, USA.
This study introduces a new framework using transcriptomics data to find novel therapeutic targets and repurpose drugs for psoriasis, a chronic inflammatory skin disease. This approach aims to accelerate the development of effective psoriasis treatments.
Area of Science:
- Dermatology
- Genomics
- Pharmacology
Background:
- Psoriasis is a chronic inflammatory skin condition with complex pathology.
- Current pharmacotherapy for psoriasis presents unmet needs.
- Transcriptomics data offers insights into disease mechanisms.
Purpose of the Study:
- To develop a framework for novel therapeutic intervention strategies for psoriasis.
- To leverage publicly available clinical transcriptomics data.
- To identify new drug repurposing opportunities and target selection methodologies.
Main Methods:
- Exploration of molecular mechanisms underlying psoriasis.
- Analysis of drug effects on perturbed molecular pathways.
- Integrative analysis of transcriptomics data.
Main Results:
- Proposal of a distinct psoriasis disease signature.
- Identification of potential drug repurposing candidates.
- Development of novel methodologies for target selection.
Conclusions:
- The proposed framework facilitates the discovery of new therapeutic targets for psoriasis.
- This approach aids in identifying existing drugs for psoriasis repurposing.
- Further development of similar methodologies can advance biomarker discovery and drug development for psoriasis.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Clinical Applications of Epidermal Stem Cells
